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Human brain evolution toward complexity has been achieved with increasing energy
supply as the main adaptation in brain metabolism. Energy metabolism, like other
biochemical reactions in aerobic cells, is under enzymatic control and strictly regulated.
Nevertheless, physiologically uncontrolled and deleterious reactions take place. It has
been proposed that these reactions constitute the basic molecular mechanisms that
underlie the maintenance or loss-of-function of neurons and, by extension, cerebral
functions during brain aging. In this review article, we focus attention on the role of the
nonenzymatic and irreversible adduction of fumarate to the protein thiols, which leads
to the formation of S-(2-succino)cysteine (2SC; protein succination) in the human brain.
In particular, we first offer a brief approach to the succination reaction, features related
to the specificity of protein succination, methods for their detection and quantification,
the bases for considering 2SC as a biomarker of mitochondrial stress, the succinated
proteome, the cross-regional differences in 2SC content, and changes during brain
aging, as well as the potential regulatory significance of fumarate and 2SC. We propose
that 2SC defines cross-regional differences of metabolic mitochondrial stress in the
human brain and that mitochondrial stress is sustained throughout the healthy adult
lifespan in order to preserve neuronal function and survival.
Keywords: cysteine, fumarate, loss-of-function, mitochondrial stress, posttranslational modification (PTM), 2-(S-
succino)cysteine (2SC), thiol groups
INTRODUCTION
A posttranslational modification (PTM) is a chemical-biological modification that takes place
to one or more amino acids on a protein after that protein has been translated by a ribosome
(Walsh, 2006). The PTM of proteins is a mechanism in all living organisms and cell types
which helps to regulate their physiological processes. PTMs allow cells to expand their protein
function and coordinate their signaling networks. These modifications have an enzymatic
origin and can be either reversible or irreversible, and they dynamically alter the structure,
stability, and functions of proteins in the cells (Walsh, 2006). Examples of PTMs include,
glycosylation, phosphorylation, acetylation, methylation, ubiquitylation, and sumoylation, among
several others. At present, around 400 PTM types have been described as affecting a significant
fraction of cell proteome (Lothrop et al., 2013). PTMs play a structural role in determining
protein folding, interaction with ligands and other proteins, and targeting specific subcellular
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compartments, as well as playing a functional role in regulating
protein turnover, catalytic activity, and signaling function,
among others (Walsh, 2006; Prabakaran et al., 2012; Santos and
Lindner, 2017).
In contrast to enzymatic PTMs, non-enzymatic PTMs
include chemical modifications mediated by reactive compounds
on proteins, which is a central event in endogenous cell
chemical damage. However, the role of several types of these
non-enzymatic and mostly irreversible modifications remains to
be elucidated. Examples of non-enzymatic PTMs are glycation,
glyco- and lipoxidation, nitrosylation, and oxidation/reduction
(Thorpe and Baynes, 2003; Golubev et al., 2017). The sulfhydryl
group of cysteine (Cys) residues in proteins are also the target
of several PTM types, including adduction to electrophiles,
glutathionylation, nitrosylation, sulphonation, sulphenation, and
sulphydration (Couvertier et al., 2014). In this review article,
we will focus on the adduction of fumarate to Cys residues in
proteins, designated as succination, its occurrence in the brain,
and its putative role in aging.
THE SUCCINATION REACTION
The adduction of fumarate to the sulfhydryl group in the side
chain of Cys residues in proteins via a Michael-like reaction at
physiological pH leads to the formation of S-(2-succino)cysteine
(2SC; Alderson et al., 2006). This non-enzymatic and irreversible
reaction, which generates a thioether bond, is called succination
of proteins in order to distinguish it from succinylation, which
is a reversible enzymatic reaction that leads to the formation
of amide, ester, or thioester bonds (Alderson et al., 2006;
Merkley et al., 2014). Chemically, succination preferentially
targets cysteine residues with low pKa values (as low as 3–4),
such as those located in active sites of proteins, in contrast
to the pKa of about nine present in the free thiol group of
cysteine and glutathione (Merkley et al., 2014). Succination
is specific for cysteine and no modification was detected in
in vitro incubations of fumarate with other candidate amino acids
like lysine and histidine in protein models, nor is it modified
like N-acetylcysteine or N-acetylhistidine (Merkley et al., 2014).
Figure 1 shows a scheme for the formation of 2SC by the reaction
of fumarate with cysteine.
The cysteine-fumarate adduct 2SC was the first described
chemical modification of proteins by a metabolite intermediate
in the Krebs cycle (Alderson et al., 2006). These findings identify
fumarate as an endogenous electrophile and suggest a potential
role for fumarate in the regulation of cell metabolism. In fact, it
has been proposed that 2SC is a biomarker of mitochondrial and
oxidative stress (Blatnik et al., 2008a).
STRUCTURAL AND FUNCTIONAL
FEATURES OF THE NONENZYMATIC
MODIFICATION OF PROTEINS BY
SUCCINATION
The analysis of the succinated proteome with 2SC sites
applying theoretical approaches to analyze sequence- and 3D-
FIGURE 1 | Mechanism of formation of 2SC. The figure shows the
conversion of glucose to pyruvate in the glycolysis pathway. Then, pyruvate is
converted to acetyl-CoA, which enters the tricarboxylic acid (TCA) cycle, and
the reducing equivalents (NADH and FADH2) generated from glycolysis and
the TCA cycle enter the mitochondrial electron transport chain (ETC). So,
glycolysis, the TCA cycle, and the ETC are integrated pathways to catabolize
energy substrates and drive ATP synthesis via the complex V (ATP synthase).
Complexes I–IV of the ETC and ATP synthase are shown. Importantly, the
nucleophilic addition of the TCA cycle metabolite fumarate to cysteine yields
2SC by a Michael addition reaction (R indicates peptide chain) in a
non-enzymatic reaction called protein succination. Fumarate can also be
exported outside mitochondria by carriers, potentially inducing 2SC formation
in other cell proteins and even at the extracellular level.
structure-based features is an excellent source of information
in order to learn about the molecular mechanism, features
related to specificity, and the role of protein succination. In
this context, a recent study by Miglio et al. (2016) collected
and examined a total of 182 succinated proteins from three
reports (Ternette et al., 2013; Merkley et al., 2014; Yang
et al., 2014) including additional information on 205 modified
and 1,750 non-modified sites. Notably, the set of modified
proteins showed a wide distribution and, although proteins are
predominantly located into the mitochondria, damaged proteins
from other locations like cytosol, endoplasmic reticulum, and
the nucleus were also detected. These observations demonstrate
that fumarate can reach other cellular and probably extracellular
compartments, likely due to the fact that fumarate can be
exported frommitochondria through specific carriers (Figure 1).
Reinforcing this, a succinate/fumarate mitochondrial transporter
(SFC1) present only in S. cerevisiae and a mitochondrial
dicarboxylate carrier (DIC) present in animal tissues (including
brain) have been described, highlighting the relevance of the
extramitochondrial transport of fumarate and the importance
of deciphering its exact molecular mechanism (Fiermonte et al.,
1999; Lin et al., 2011). Thus, fumarate seems to behave like
a long-lived reactive compound and can be more damaging
because it has a more prominent global impact in altering a wider
collection of protein targets beyond mitochondria due to their
transient nature.
The analysis of the succinated proteome also suggests that
protein modification is not restricted to proteins of a specific
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metabolic-biological process or molecular function, suggesting
that succination may have wide-ranging effects on the structural
cell components and the regulation of metabolism. Thus,
proteins involved in cytoskeleton organization, ion (iron, zinc,
and copper) homeostasis, metabolic processes (amino acids,
carbohydrates, fatty acids, and nucleotides metabolism), protein
synthesis, redox homeostasis, RNA processing, and signaling
pathways are modified (Nagai et al., 2007; Ternette et al., 2013;
Merkley et al., 2014; Yang et al., 2014). Interestingly, more
than 80% of succinated proteome showed a single 2SC site,
with the 2SC sites ranging from 1 to 3 per protein, and the
overall relative abundance of modifiable sites is 10.8% (Miglio
et al., 2016). These findings demonstrate the heterogeneity of the
modified proteins, reinforces the non-specific character of this
PTM type and confirms that only certain Cys residues can react
with fumarate to generate 2SC. Consequently, these observations
confirm the existence of features of Cys residues that govern the
specificity of 2SC formation and confirm the selectivity of the
modification for particular proteins.
Finally, the analysis of 2SC site features demonstrated that
modified and non-modified sites may be differentiated when
the accessibility of the sulphur atoms and the amino acid
composition of the Cys-flaking peptides is analyzed, whereas
these were not distinguishable when the ‘‘acid dissociation
constant value of the sulfhydryl groups,’’ the ‘‘hydrophobicity of
the Cys-flaking peptides,’’ and the ‘‘secondary structure of the
Cys-containing segments’’ were compared (Miglio et al., 2016).
METHODS FOR DETECTING
SUCCINATION OF PROTEINS
Currently, mass spectrometry (MS)-based analysis and antibody-
based detection techniques are the main methods used to detect
and analyze protein succination. However, the MS approach is
the only available tool for global or large-scale analysis.
The availability of specific antibodies that can recognize
modified amino acid residues within a peptide or protein
conditions antibody-based methods. These antibodies can be
monoclonal or polyclonal and are developed against either the
modified amino acid or peptide/protein. Later, the quantification
of PTMs on peptide/protein using antibody-based techniques
can be done with two methods: absorbance/fluorescence-
based ELISA and chemiluminescence-based Western blotting.
In any case, the detection of PTMs absolutely depends on
the recognition site of the antibody applied. For succinated
proteins a characterized polyclonal antibody against 2SC for
immunoblot analysis, two-dimensional PAGE analysis, and
immunohistochemistry has been systematically used (Nagai
et al., 2007; Frizzell et al., 2009, 2012; Bardella et al., 2011; Thomas
et al., 2012; Manuel and Frizzell, 2013; Ternette et al., 2013;
Merkley et al., 2014; Piroli et al., 2014, 2016; Yang et al., 2014).
MS detection of specific 2SC sites is based on mass changes.
Using liquid chromatography-electrospray ionization-MS (LC-
ESI-MS)-based proteomics analysis, subsequent fragmentation
and sequencing of a relevant peptide has been used to identify
specific site of succination (Blatnik et al., 2008a; Frizzell et al.,
2009; Ternette et al., 2013; Merkley et al., 2014; Piroli et al.,
2014, 2016; Yang et al., 2014). Yet, technical challenges hamper
MS-based investigation of the succination of proteins, many
of them linked to or derived from the low-abundance of this
non-enzymatic modification (Merkley et al., 2014).
MS-based techniques—specifically gas chromatography-MS
(GC/MS)—can also be used to detect and measure the steady-
state level of 2SC at the subcellular, cellular, tissue, and organ
levels (Nagai et al., 2005, 2007; Alderson et al., 2006; Blatnik
et al., 2008a; Frizzell et al., 2009; Cabré, 2015; Gomez et al.,
2015; López-González et al., 2015; Cabré et al., 2016, 2017;
Martínez-Cisuelo et al., 2016; Piroli et al., 2016; Naudí et al.,
2017). In this approach, 2SC can be determined as TFAME
(trifluoroacetic acid methyl esters) derivatives in protein samples
(around 0.5–1 mg of protein final concentration) previously
hydrolyzed in acidic conditions and using a GC coupled to
an MS, an HP-5MS column (30 m × 0.25 mm × 0.25 µm),
and a specific temperature program ranging from 110◦C to
300◦C. Later, quantification can bemade by internal and external
standardization using standard curves created from mixtures
of deuterated and non-deuterated standards. Analyses can be
carried out with SIM-GC/MS (selected ion-monitoring GC/MS).
In this case, the ions used for detection and quantification are
lysine and [2H8]lysine, m/z 180 and 187, respectively; and 2SC
and [2H2]2SC, m/z 284 and 286, respectively. Thus, the amount
of product can be expressed as mili- or micromoles of 2SC per
mol of lysine. Figure 2 shows the detection and quantification by




The detection of the protein adduct 2SC in a biological system
was originally demonstrated in human erythrocytes (globin;
Nagai et al., 2005), plasma proteins (albumin), and skin collagen
(Alderson et al., 2006). Interestingly, 2SC increases in human
skin collagen with age (Alderson et al., 2006). Later, the presence
of this post-translational Cys modification type was extended to
three pathological models: diabetes/obesity, fumarate hydratase
(FH)-related diseases, and Leigh syndrome. In all these models,
increased steady-state levels of 2SC were found due to increased
levels of fumarate ascribed to dysfunctional mitochondrial
metabolic activity. More specifically, increased levels of 2SC
were found in erythrocytes and adipocytes (murine 3T3-L1
adipocytes) cultured in high glucose medium (30 mM, compared
with the physiological concentration of 5 mM; Nagai et al.,
2005, 2007; Frizzell et al., 2012; Manuel and Frizzell, 2013; Piroli
et al., 2014; Manuel et al., 2017), as well as in tissues (e.g.,
adipose tissue, skeletal muscle or urine) from streptozotocin-
treated rats—a model of type 1 diabetes—(Alderson et al.,
2006; Blatnik et al., 2008b; Thomas et al., 2012), db/db
(leptin receptor deficient; Frizzell et al., 2009; Thomas et al.,
2012; Piroli et al., 2014; Manuel et al., 2017), Akita diabetic
mice (Thomas et al., 2012), ob/ob (leptin deficient; Thomas
et al., 2012), and diet-induced obese mice (Thomas et al.,
2012). In all these models, the proposed underlying molecular
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FIGURE 2 | Detection and quantification by GC/mass spectrometry (MS)/MS of 2SC in human brain samples. 2SC can be determined as trifluoroacetic acid methyl
ester (TFAME) derivatives in acid hydrolyzed, delipidated, and reduced brain protein samples by GC/MS. (A) Structure, mass spectrum, and proposed fragmentation
patterns of TFAME derivative of natural 2SC. (B) Detection of 2SC in human brain proteins. Selected ion chromatograms for brain proteins showing the
m/z = 242 and m/z = 284 ions. (C) 2SC quantification in different regions of the human brain (adapted from Cabré et al., 2016 with permission). *p < 0.05. A
significant difference with respect to the entorhinal cortex.
mechanism is related to the excess of nutrients and implies
an elevated ATP/ADP and NADH/NAD+ ratios as well as
an elevated mitochondrial membrane potential. The increased
NADH/NAD+ ratio down-regulates oxidative phosphorylation,
leading to sustained accumulation of mitochondrial metabolites
including fumarate, which, in turn, gives rise to protein
succination (Frizzell et al., 2012).
An increased concentration of succinated proteins has also
been reported in a pathological model based on FH enzyme
loss-of-function (Bardella et al., 2011; Ternette et al., 2013; Yang
et al., 2014). FH catalyzes the reversible conversion of fumarate
to malate in the tricarboxylic acid cycle (TCA or Krebs cycle).
In this model, protein succination is involved in FH-related
carcinogenesis (Bardella et al., 2011; Ternette et al., 2013; Yang
et al., 2014), and more importantly, has been proposed as acting
as an oncometabolite (Yang et al., 2012).
Finally, increased levels of 2SC have also been described in the
brainstem ofNdufs4 knockout mice (a model of Leigh syndrome;
Piroli et al., 2016), suggesting a potential role for protein
succination in the physiopathogenesis of this mitochondrial
disorder. Ndufs4 is a subunit of the mitochondrial complex I
which plays a key structural role, allowing the correct assembly,
stability, and activity of this complex and, consequently, the
correct function of the mitochondrial electron transport chain
(ETC) and the subsequent energy production. Mutations in
Ndfus4 produce a defective mitochondrial energy metabolism,
and animals develop fatal encephalomyopathy with premature
death which recapitulates the signs of Leigh syndrome.
Together, these observations indicate that increased 2SC
content in tissue proteins is a direct consequence of increased
intracellular fumarate concentration. For this reason, 2SC has
been proposed as a biomarker of metabolic stress, and more
specifically, of mitochondrial stress (Nagai et al., 2007; Blatnik
et al., 2008a; Frizzell et al., 2009, 2012; Thomas et al., 2012).
Succination has been reported in almost all tissues analyzed
using immunoblotting and mass spectrometric techniques,
although the degree of modification varies significantly among
them. Thus, the detection of 2SC by immunoblotting shows that
there are tissue-specific differences in the renal medulla and
cortex, testes, lungs, soleus, gastrocnemius, heart, liver, spleen,
and fat (suprarenal, subcutaneous, and epididymal adipose
tissue; Thomas et al., 2012). In line with this, the presence of
2SC was also described in liver mitochondria from rats and mice
(Gomez et al., 2015; Martínez-Cisuelo et al., 2016), and in several
brain regions from humans, rat, and mice (Cabré, 2015; López-
González et al., 2015; Cabré et al., 2016; Naudí et al., 2017)
using MS techniques. Table 1 shows the steady-state levels of
2SC measured by GC/MS in different brain regions, tissues, and
species. Notably, the steady-state level of 2SC is in the range of
micromoles 2SC/mol lysine, clearly indicating the low abundance
of this post-translational modification at the tissue level.
S-(2-SUCCINO)CYSTEINE (2SC) IN
HUMAN BRAIN TISSUE
Human brain evolution is closely associated with the expansion
of its size and complexity, a key condition for the appearance
of cognitive functions, demanding adaptations in brain energy
metabolism (Somel et al., 2013; Cabré et al., 2016). The main
energy provider for neurons and glial cells is the mitochondrion.
Consequently, it is reasonable to propose that these cell types can
be particularly susceptible to succination of proteins. Effectively,
the available evidence demonstrates that protein succination
occurs in brain tissue as in other cell systems. Thus, the
formation of 2SC has been described in several brain regions
in mouse (López-González et al., 2015; Piroli et al., 2016), rat
(Cabré, 2015) and human (Cabré et al., 2016, 2017; Naudí
et al., 2017). By using immunoblotting, 2SC was detected in
several mouse brain areas including olfactory bulb, cortex,
striatum, cerebellum, and brainstem (Piroli et al., 2016). By using
MS, 2SC was analyzed in somatosensory cortex, hippocampus,
and spinal cord (lumbar) in mouse (López-González et al.,
2015); cortex (temporal, occipital, and frontal), hippocampus,
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TABLE 1 | Steady-state levels of 2SC measured by gas chromatography/mass
spectrometry (GC/MS) in different brain regions, tissues and species.
Tissue Species Concentration Reference
Spinal cord Human 0.101 Naudí et al. (2017)
Medulla oblongata Human 0.112 Naudí et al. (2017)
Cerebellum Human 0.060 Naudí et al. (2017)
Substantia nigra Human 0.115 Naudí et al. (2017)
Thalamus Human 0.084 Naudí et al. (2017)
Amygdala Human 0.086 Naudí et al. (2017)
Striatum Human 0.080 Naudí et al. (2017)
Entorhinal cortex Human 0.075 Naudí et al. (2017)
Entorhinal cortex Human 0.078 Cabré et al. (2016)
Hippocampus Human 0.062 Naudí et al. (2017)
Hippocampus Human 0.063 Cabré et al. (2016)
Temporal cortex Human 0.044 Naudí et al. (2017)
Occipital cortex Human 0.046 Naudí et al. (2017)
Frontal cortex Human 0.058 Naudí et al. (2017)
Frontal cortex Human 0.059 Cabré et al. (2016)
Spinal cord (lumbar) Rat 0.019 Cabré (2015)
Spinal cord
(thoracic)
Rat 0.015 Cabré (2015)
Spinal cord
(cervical)
Rat 0.018 Cabré (2015)
Medulla oblongata Rat 0.040 Cabré (2015)
Pons Rat 0.048 Cabré (2015)
Cerebellum Rat 0.039 Cabré (2015)
Olfactory bulb Rat 0.051 Cabré (2015)
Thalamus Rat 0.042 Cabré (2015)
Hypothalamus Rat 0.047 Cabré (2015)
Striatum Rat 0.060 Cabré (2015)
Hippocampus Rat 0.047 Cabré (2015)
Temporal cortex Rat 0.041 Cabré (2015)
Occipital cortex Rat 0.044 Cabré (2015)
Frontal cortex Rat 0.028 Cabré (2015)
Somatosensory
cortex
Mouse 0.062 López-González et al.
(2015)
Hippocampus Mouse 0.079 López-González et al.
(2015)
Spinal cord (lumbar) Mouse 0.042 López-González et al.
(2015)
Erythrocytes Human 0.016 Nagai et al. (2005)
Plasma proteins
(albumin)
Human 0.6 Alderson et al. (2006)
Skin collagen Human 0.06 Alderson et al. (2006)




Mouse 0.060 Frizzell et al. (2009)
Liver mitochondria Rat 0.083 Gomez et al. (2015)
Skeletal muscle Rat 0.007 Alderson et al. (2006)
Skeletal muscle Rat 0.007 Blatnik et al. (2008a)
Urine Rat 120∗ Alderson et al. (2006)
Data are from healthy adult individuals or specimens. Units: mmol 2SC/mol lysine.
∗nmol/day.
striatum, hypothalamus, thalamus, olfactory bulb, cerebellum,
pons, medulla oblongata, and spinal cord (lumbar, thoracic and
cervical) in rat (Cabré, 2015); and cortex (occipital, temporal, and
frontal), hippocampus, entorhinal cortex, striatum, amygdala,
substantia nigra, thalamus, cerebellum, medulla oblongata, and
spinal cord in human (Cabré et al., 2016; Naudí et al., 2017).
Table 1 shows the steady-state levels of 2SC measured by GC/MS
in different brain regions and species. So, 2SC concentration
ranged from 0.042 to 0.079 mmoles of 2Sc/mol lys in mice, from
0.015 to 0.060mmoles of 2SC/mol lys in rats (see also Figure 3C),
FIGURE 3 | (A) Concentrations of fumarate (left) and 2SC (right) in different
regions of the adult human cerebral cortex. Fumarate was detected and
quantified with TQMS. The steady-state level of 2SC was measured with
GC-MS. *p < 0.05; **p < 0.01. A significant difference with respect to the
entorhinal cortex (adapted from Cabré et al., 2016 with permission). (B)
Steady-state levels of 2SC in 12 regions of the adult healthy human central
nervous system show a significant inverse correlation following a
caudal-cranial axis (σ(rho) = −0.672, p < 0.001; adapted from Naudí et al.,
2017 with permission). Values are mean ± SEM from 5–8 samples for each
region. Abbreviations: SC, spinal cord; MO, medulla oblongata; CB,
cerebellum; SN, substantia nigra; TH, thalamus; AM, amygdala; ST, striatum;
EC, entorhinal cortex; HC, hippocampus; TC, temporal cortex; OC, occipital
cortex; FC, frontal cortex. rho (σ), Spearman’s rank correlation coefficient. (C)
Effects of aging and methionine restriction in old age on the concentration of
2SC in 13 different brain regions of rat. Values are mean ± SEM from
10 animals per group for each region. Abbreviations: SC, spinal cord (L,
lumbar; T, thoracic; C, cervical); MO, medulla oblongata; P, pons; CB,
cerebellum; TH, thalamus; HT, hypothalamus; ST, striatum; HC,
hippocampus; TC, temporal cortex; OC, occipital cortex; FC, frontal cortex.
and from 0.044 to 0.112 mmoles of 2SC/mol lys in humans.
Notably, the higher 2SC concentration seems to be present in
the human brain, likely as an expression of the higher energy
demands. This range of protein succination is consistent with
the notion of the low abundance of this non-enzymatic PTM.
Furthermore, the findings from the immunoblotting approach
also confirm the selectivity of the succinated proteins and the
presence of cross-regional differences (Piroli et al., 2016), as well
the relationship between fumarate content and the degree of
protein succination (Cabré et al., 2016; see Figure 3A).
The findings in the human brain are particularly interesting.
Thus, the comparison of 12 brain regions (frontal cortex,
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FIGURE 4 | Protein succination may mediate neuroprotection by the activation of signaling pathways modulated by Nrf2. The transcription factor Nrf2 regulates the
expression of genes encoding proteins with broad cytoprotective activities and mitochondrial functions. Nrf2 itself is regulated at the level of protein stability. Under
baseline physiological conditions, Nrf2 is a short-lived protein that is exposed to incessant turnover via ubiquitination and proteasomal degradation. There are three
known ubiquitin ligase systems that participate in the removal of Nrf2: (a) Keap1, a substrate adaptor protein for Cullin 3 (Cul3)/Rbx1 ubiquitin ligase; (b) glycogen
synthase kinase (GSK)3/β-TrCP-dependent Cul1-based ubiquitin ligase; and (c) E3 ubiquitin ligase Hrd1. In addition to the ubiquitin ligase substrate adaptor protein
activity, Keap1 is also the sensor for a wide array of small-molecule activators of Nrf2 (called inducers). Oxidants like reactive oxygen and nitrogen species,
electrophiles like carbonyl compounds derived from lipid peroxidation or carbohydrates oxidation, and fumarate are all considered inducers. Inducers block the cycle
of Keap1-mediated degradation of Nrf2 by chemically modifying (e.g., by protein succination) specific cysteine residues within Keap1 (Keap1 is a cysteine-rich
protein; e.g., rat and mouse have 25 and human 27) or by directly disrupting the Keap1: Nrf2 binding interface. Consequently, Nrf2 is not degraded; it accumulates
and translocates to the nucleus, forms a heterodimer with a small Maf protein, binds to antioxidant-response elements (AREs), and initiates transcription.
occipital cortex, temporal cortex, hippocampus, entorhinal
cortex, striatum, amygdala, thalamus, substantia nigra,
cerebellum, medulla oblongata, and spinal cord) uncovered
the existence of cross-regional differences in the steady-state
levels of 2SC in the human central nervous system, and, in
consequence, it established a region-dependent vulnerability
(Naudí et al., 2017; see also Table 1, Figure 3B). Notably, the
relationship between 2SC and its distribution following the main
subdivisions of the embryonic vertebrate brain according to the
cranial-caudal axis (from cerebral cortex to spinal cord) verified
that the higher (more cranial) the human brain region, the
lower the 2SC content (σ(rho) = −0.672, p < 0.001; Figure 3B),
suggesting a lower mitochondrial stress in the superior human
brain regions (Naudí et al., 2017).
PROTEIN SUCCINATION DURING HUMAN
BRAIN AGING
Brain aging is an endogenous, and deleterious, physiological
process characterized by structural and functional changes at
different levels of the biological organization, leading to loss of
function at the cognitive, regulatory, motor, and sensitive levels
(Bishop et al., 2010). Indeed, functional decline and specifically,
cognitive loss, are a health challenge for the current century.
This challenge is derived from the increased longevity of the
general population which attests to the increase in the prevalence
of cognitive decline, dementia, and Alzheimer’s disease. In fact,
aging is the main cause and risk factor for cognitive deterioration
and Alzheimer’s disease in the elderly.
Functional studies have identified phenotypes and signaling
pathways that affect and modulate aging in model organisms
and brain aging in mammalian species (human included).
Among these, are changes in both mitochondrial and synaptic
function (Bishop et al., 2010). Importantly, and in contrast
to Alzheimer’s disease pathology and other neurodegenerative
diseases, human neuronal cells are functional throughout the
entire healthy adult lifespan. Consequently, it may be postulated
that the maintenance of neuronal function throughout the
healthy adult lifespan must be sustained, at least in part, by the
ability of neurons to maintain the metabolic conditions at the
mitochondrial level under strict control. In this context, 2SC, as a
biomarker of mitochondrial stress, can be a good indicator of the
mitochondrial metabolic status and aging.
With this premise, different non-enzymatic PTMs were
analyzed in the frontal cortex of healthy humans covering
an age range from 40 to 90 years old, using MS (Cabré
et al., 2017). The results demonstrated increased protein
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oxidative (aminoadipic- and glutamic- semialdehyde markers)
and lipo- and glycoxidative (carboxyethyl- and carboxymethyl-
lysine markers) damage in human frontal cortex during the
healthy adult lifespan, with a breakpoint at 60 years old
(Cabré et al., 2017). Remarkably, this accumulation of oxidative
damage with age is selective because when compared with
the non-enzymatic modification of cysteine residues (2SC and
carboxymethyl-cysteine), no changes were observed. These
findings suggest better protection of cysteine residues and
their properties by specific and reversible mechanisms such
as S-sulfhydration and polysulfidation to prevent cysteine
irreversible modification (Takata et al., 2019; Zivanovic et al.,
2019), and suggest that in human frontal cortex mitochondrial
metabolic stress is strictly sustained within physiological
limits throughout the healthy adult lifespan, being a key
mechanism in supporting neuronal function and survival
(Cabré et al., 2017).
Reinforcing this observation and idea, the measurement of
2SC in different brain regions of adults and aged rats offers very
similar results (Cabré, 2015). Specifically, in order to analyze
the potential changes induced by age during adult lifespan, 2SC
was measured in 14 different brain regions [spinal cord (lumbar,
thoracic and cervical), medulla oblongata, pons, cerebellum,
olfactory bulb, thalamus, hypothalamus, striatum, hippocampus,
and cortex (temporal, occipital, and frontal)] of rats arranged
into two age groups: adults (8 months) and aged (26 months).
The results demonstrated non-significant changes with aging
for all analyzed regions, clearly suggesting that mitochondrial
stress is also maintained throughout the adult healthy lifespan
(Figure 3C). Interestingly, the application of an anti-aging
nutritional intervention like methionine restriction (Pamplona
and Barja, 2006) in old age allowed the maintaining of steady-
state concentrations of 2SC at adult levels in all brain regions
(Cabré, 2015; Figure 3C).
POTENTIAL REGULATORY SIGNIFICANCE
OF FUMARATE AND 2SC
By reacting with nucleophilic sites to proteins involving Cys
residues, the Krebs cycle metabolite fumarate generates 2SC.
2SC has been detected, characterized, and localized in the
human brain.
The molecular effects of 2SC generation on proteins mostly
comprise deleterious structural and functional changes. Thus,
the functional consequences of protein succination include a
loss of function of the target protein (Blatnik et al., 2008a;
Frizzell et al., 2009; Ternette et al., 2013; Piroli et al., 2014). In
a similar way to other non-enzymatic PTMs, protein succination
can also induce alterations in their physical-chemical properties
such as solubility, hydrophobicity, conformation, and charge,
among others.
In contrast, 2SC formation can also mean protein activation
when the target protein is structurally and functionally designed
to sense and respond to cellular fumarate production. Besides
their cytotoxic roles, fumarate and 2SC also exert neuroprotective
effects through the activation of adaptive responses specifically
designed to decrease the impact of protein damage and relieve
mitochondrial stress. One of the mechanisms involved is the
antioxidant response signaling pathway Nrf2 (Nuclear factor
erythroid 2-related factor 2) subsequent to the succination of
Keap1 (Kelch-like ECH-associated protein 1; Figure 4).
Nrf2 is a transcriptional factor that acts as master regulator
of the cell antioxidant defenses and the mitochondrial function
in order to maintain and adapt redox homeostasis of neuronal
and glial cells (Dinkova-Kostova and Abramov, 2015; Johnson
and Johnson, 2015; Yamazaki et al., 2015; Baxter and
Hardingham, 2016; Vasconcelos et al., 2019). Nrf2 modulates
the expression of more than 200 genes by binding to a
promoter element called ARE (antioxidant response element)
present in these genes. These genes encode for proteins involved
in cytoprotection (including antioxidant, anti-inflammatory,
detoxification, repair, and removal activities), maintenance of
redox homeostasis (biosynthesis of glutathione, thioredoxin,
and NADPH), control of mitochondrial ROS (reactive oxygen
species) production (by uncoupling proteins), mitochondrial
function (ATP synthesis, availability of substrates for ETC,
fatty acid oxidation, and membrane potential), mitochondrial
biogenesis, and mitochondrial integrity (Dinkova-Kostova and
Abramov, 2015).
The association between fumarate and the Nrf2 pathway
was based on indirect evidence from pathological models in
which there was a deficiency in the FH enzyme which converts
fumarate to malate in the Krebs cycle, with a subsequently
increased concentration of fumarate. In these models (human
FH-deficient cells and tissues, mouse embryonic fibroblasts,
and Fh1 deficient renal cyst model (Adam et al., 2011; Ooi
et al., 2011) an up-regulation of the Nrf2 pathway was observed,
suggesting the potential succination of the Keap1 protein. The
succination of Keap1 was later confirmed, and the specific
modified sites which correspond to two critical cysteine residues
were identified: Cys155 and Cys288. These modified sites disrupt
the interaction of Keap1-Nrf2, resulting in stabilization and
accumulation of Nrf2 in the nucleus, binding to AREs, and
subsequent activation of target genes (Adam et al., 2011; Ooi
et al., 2011). In this context, it is proposed that fumarate,
by affecting the Nrf2 pathway, may contribute to neuronal
protection, analogously to other cell types, by enabling them to
tolerate different degrees of mitochondrial stress, thus promoting
cell survival.
PERSPECTIVES
Succination may induce the structural and functional alteration
of cellular and extracellular proteins, and it offers a mechanism
by which a Krebs cycle metabolite may lead to defects in the
metabolism of neuronal and glial cells. Although it is not possible
to offer comprehensive coverage of succinated proteome in the
brain, advances in metabolomics and proteomics should yield
further findings on the distribution at the subcellular, cell type,
and regional levels of fumarate content and succinated proteome,
as well as the cellular functions, affected. Systems biology will
allow, in coming years, the development of an accurate view of
the role of succination in defining and determining the selective
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vulnerability of all cell types that make up the human brain,
as well as for an elucidation of the main factors in the brain
aging process and, perhaps, neurodegeneration. Further studies
are needed to consolidate these concepts.
CONCLUSIONS
Succination is a non-enzymatic PTM of cysteine by the Krebs
cycle metabolite fumarate, leading to the generation of 2SC,
which is considered a biomarker of mitochondrial stress. There
is a specificity of protein succination linked to structural and
functional features. MS and antibody-based methods are the
predominant approaches to detecting and quantifying protein
succination, which occurs in brain tissue as in other cell systems.
However, the concentration of 2SC in the human brain is region-
specific. No changes have been detected in 2SC content in several
brain regions throughout a healthy adult life span, suggesting
sustained mitochondrial stress during aging which may support
neuronal function and survival.
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